Genetic Analysis of Human Norovirus Strains in Japan in 2016–2017

Koo Nagasawa(National Institute of Infectious Diseases), Yuki Matsushima(Kawasaki Hospital), Takumi Motoya(Ibaraki Prefectural Police), Fuminori Mizukoshi(Tochigi Prefectural Police), Yo Ueki, Naomi Sakon(Osaka Prefectural Institute of Public Health), Koichi Murakami(National Institute of Infectious Diseases), Tomomi Shimizu(Kawasaki Hospital), Nobuhiko Okabe(Kawasaki Hospital), Noriko Nagata(Ibaraki Prefectural Police), Komei Shirabe, Hiroto Shinomiya(Shimane Prefectural Institute of Public Health and Environmental Sciences), Wataru Suzuki(Eiken Chemical (Japan)), Makoto Kuroda(National Institute of Infectious Diseases), Tsuyoshi Sekizuka(National Institute of Infectious Diseases), Yoshiyuki Suzuki(Nagoya City University), Akihide Ryo(Yokohama City University), Kiyotaka Fujita(Gumma Paz College), Kazunori Oishi(National Institute of Infectious Diseases), Kazuhiko Katayama(Kitasato University), Hirokazu Kimura(Gumma Paz College)
Frontiers in Microbiology
January 17, 2018
Cited by 1,265Open Access
Full Text

Abstract

In the 2016/17 winter season in Japan, HuNoV GII.P16-GII.2 strains (2016 strains) emerged and caused large outbreaks of acute gastroenteritis. To better understand the outbreaks, we examined the molecular evolution of the VP1 gene and RdRp region in 2016 strains from patients by studying their time-scale evolutionary phylogeny, positive/negative selection, conformational epitopes, and phylodynamics. The time-scale phylogeny suggested that the common ancestors of the 2016 strains VP1 gene and RdRp region diverged in 2006 and 1999, respectively, and that the 2016 strain was the progeny of a pre-2016 GII.2. The evolutionary rates of the VP1 gene and RdRp region were around 10−3 substitutions/site/year. Amino acid substitutions (position 341) in an epitope in the P2 domain of 2016 strains were not found in pre-2016 GII.2 strains. Bayesian skyline plot analyses showed that the effective population size of the VP1 gene in GII.2 strains was almost constant for those 50 years, although the number of patients with NoV GII.2 increased in 2016. The 2016 strain may be involved in future outbreaks in Japan and elsewhere.


Related Papers

No related papers found

Powered by citation graph analysis